Key result
Reprogramming peripheral blood mononuclear cells from an HCM patient with a MYBPC3 mutation successfully generated an iPSC line exhibiting normal morphology, karyotype, and pluripotency.
Why the study?
MYBPC3 is the most frequently mutated gene leading to HCM, an inherited cardiovascular disorder with elevated risk of sudden cardiac death.
The establishment of this patient-specific iPSC line provides a valuable in vitro model for studying the disease mechanisms of HCM associated with the MYBPC3 c.3072C > A mutation.
Answers are grounded in this paper and cite their sources.
iPSC model from MYBPC3-mutant HCM patient generated; leaves open utility for mechanistic studies or drug testing.
Hypertrophic cardiomyopathy (HCM) is an inherited cardiovascular disorder characterized by left ventricular hypertrophy and an elevated risk of sudden cardiac death. Cardiac myosin binding protein C (MYBPC3) is the most frequently mutated gene leading to HCM. In this study, peripheral blood mononuclear cells isolated from an HCM patient harboring a heterozygous MYBPC3 missense mutation (c.3072C > A; p.S1024R) were reprogrammed via Sendai virus vectors to generate a patient-specific induced pluripotent stem cell (iPSC) line. The iPSC line exhibits normal morphology and karyotype, alongside definitive hallmarks of pluripotency, including trilineage differentiation potential.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2025) studied Hypertrophic cardiomyopathy (n=1). Reprogramming via Sendai virus vectors was evaluated on Generation of a patient-specific induced pluripotent stem cell (iPSC) line. Reprogramming peripheral blood mononuclear cells from an HCM patient with a MYBPC3 mutation successfully generated an iPSC line exhibiting normal morphology, karyotype, and pluripotency.
Synapse has enriched 10 related papers. Consider them for comparative context: